Thomas CP - Search Results

1

Screening of Living Kidney Donors for Genetic Diseases Using a Comprehensive Genetic Testing Strategy.

Thomas CP, Mansilla MA, Sompallae R, Mason SO, Nishimura CJ, Kimble MJ, Campbell CA, Kwitek AE, Darbro BW, Stewart ZA, Smith RJ. Thomas CP, et al. Am J Transplant. 2017 Feb;17(2):401-410. doi: 10.1111/ajt.13970. Epub 2016 Aug 24. Am J Transplant. 2017. PMID: 27434427 Free PMC article.

2

Early postnephrectomy donor renal function: laparoscopic versus open procedure.

Vats HS, Rayhill SC, Thomas CP. Vats HS, et al. Among authors: thomas cp. Transplantation. 2005 Mar 15;79(5):609-12. doi: 10.1097/01.tp.0000151662.84962.4e. Transplantation. 2005. PMID: 15753853

3

Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipient.

Chan MR, Thomas CP, Torrealba JR, Djamali A, Fernandez LA, Nishimura CJ, Smith RJ, Samaniego MD. Chan MR, et al. Among authors: thomas cp. Am J Kidney Dis. 2009 Feb;53(2):321-6. doi: 10.1053/j.ajkd.2008.06.027. Epub 2008 Sep 21. Am J Kidney Dis. 2009. PMID: 18805611 Free PMC article.

4

Unrecognized acute phosphate nephropathy in a kidney donor with consequent poor allograft outcome.

Agrawal N, Nair R, McChesney LP, Tuteja S, Suneja M, Thomas CP. Agrawal N, et al. Among authors: thomas cp. Am J Transplant. 2009 Jul;9(7):1685-9. doi: 10.1111/j.1600-6143.2009.02686.x. Epub 2009 Jun 10. Am J Transplant. 2009. PMID: 19519817 Free article.

5

Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome.

Nester C, Stewart Z, Myers D, Jetton J, Nair R, Reed A, Thomas C, Smith R, Brophy P. Nester C, et al. Clin J Am Soc Nephrol. 2011 Jun;6(6):1488-94. doi: 10.2215/CJN.10181110. Epub 2011 May 26. Clin J Am Soc Nephrol. 2011. PMID: 21617085 Free PMC article.

6

Case report: Eculizumab rescue of severe accelerated antibody-mediated rejection after ABO-incompatible kidney transplant.

Stewart ZA, Collins TE, Schlueter AJ, Raife TI, Holanda DG, Nair R, Reed AI, Thomas CP. Stewart ZA, et al. Among authors: thomas cp. Transplant Proc. 2012 Dec;44(10):3033-6. doi: 10.1016/j.transproceed.2012.03.053. Epub 2012 Sep 6. Transplant Proc. 2012. PMID: 23195021

7

Tailored eculizumab therapy in the management of complement factor H-mediated atypical hemolytic uremic syndrome in an adult kidney transplant recipient: a case report.

Xie L, Nester CM, Reed AI, Zhang Y, Smith RJ, Thomas CP. Xie L, et al. Among authors: thomas cp. Transplant Proc. 2012 Dec;44(10):3037-40. doi: 10.1016/j.transproceed.2012.07.141. Transplant Proc. 2012. PMID: 23195022

8

Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome.

Bu F, Maga T, Meyer NC, Wang K, Thomas CP, Nester CM, Smith RJ. Bu F, et al. Among authors: thomas cp. J Am Soc Nephrol. 2014 Jan;25(1):55-64. doi: 10.1681/ASN.2013050453. Epub 2013 Sep 12. J Am Soc Nephrol. 2014. PMID: 24029428 Free PMC article.

9

The challenge in diagnosing de novo minimal change disease after transplantation.

Kuppachi S, Suneja M, Stewart Z, Nair R, Thomas CP. Kuppachi S, et al. Among authors: thomas cp. Transplantation. 2015 Feb;99(2):e11-2. doi: 10.1097/TP.0000000000000550. Transplantation. 2015. PMID: 25651122 No abstract available.

10

Soluble c5b-9 as a biomarker for complement activation in atypical hemolytic uremic syndrome.

Bu F, Meyer NC, Zhang Y, Borsa NG, Thomas C, Nester C, Smith RJ. Bu F, et al. Am J Kidney Dis. 2015 Jun;65(6):968-9. doi: 10.1053/j.ajkd.2015.02.326. Epub 2015 Mar 25. Am J Kidney Dis. 2015. PMID: 25818678 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

274 results

Search Page

Filters